Viewing Study NCT01511393


Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2026-01-06 @ 2:28 AM
Study NCT ID: NCT01511393
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2023-06-13
First Post: 2011-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 2 View
None Medullary Thyroid Carcinoma View
None Weight Management View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GLP1 View
None Glucagon like peptide View
None liraglutide View
None exenatide extended release View
None dulaglutide View
None semaglutide View
None semaglutide tablets View